X-46837108-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_006915.3(RP2):āc.8G>Cā(p.Cys3Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000926 in 1,166,907 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 29 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000045 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.000098 ( 0 hom. 29 hem. )
Consequence
RP2
NM_006915.3 missense
NM_006915.3 missense
Scores
9
3
5
Clinical Significance
Conservation
PhyloP100: 4.61
Genes affected
RP2 (HGNC:10274): (RP2 activator of ARL3 GTPase) The RP2 locus has been implicated as one cause of X-linked retinitis pigmentosa. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Progressive retinal degeneration may therefore be due to the accumulation of incorrectly-folded photoreceptor or neuron-specific tubulin isoforms followed by progressive cell death [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.959
BS2
High Hemizygotes in GnomAdExome4 at 29 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RP2 | NM_006915.3 | c.8G>C | p.Cys3Ser | missense_variant | 1/5 | ENST00000218340.4 | NP_008846.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RP2 | ENST00000218340.4 | c.8G>C | p.Cys3Ser | missense_variant | 1/5 | 1 | NM_006915.3 | ENSP00000218340 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112270Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34404
GnomAD3 genomes
AF:
AC:
5
AN:
112270
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34404
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000605 AC: 7AN: 115651Hom.: 0 AF XY: 0.0000734 AC XY: 3AN XY: 40875
GnomAD3 exomes
AF:
AC:
7
AN:
115651
Hom.:
AF XY:
AC XY:
3
AN XY:
40875
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000977 AC: 103AN: 1054637Hom.: 0 Cov.: 30 AF XY: 0.0000840 AC XY: 29AN XY: 345043
GnomAD4 exome
AF:
AC:
103
AN:
1054637
Hom.:
Cov.:
30
AF XY:
AC XY:
29
AN XY:
345043
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112270Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34404
GnomAD4 genome
AF:
AC:
5
AN:
112270
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
6
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | RP2: PS4:Moderate, PP4, PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 28, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 20729296, 28209709, 20106869, 12037013, 22072390, 34906488, 23150612, 10942419, 20625056) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinitis pigmentosa 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jun 24, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3A. The following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with retinitis pigmentosa 2 (MIM# 312600). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from cysteine to serine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2) (4 heterozygotes, 0 homozygotes, 3 hemizygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0601 - Variant is located in the N-terminal consensus myristoylation and palmitoylation motif where the cysteine-3 amino acid represents the site of palmitoylation (PMID 10942419, 12037013, Uniprot). (SP) 0803 - This variant has limited previous evidence of pathogenicity. This variant has previously been reported as likely pathogenic (ClinVar) and in a patient with X-linked retinitis pigmentosa (PMIDs: 20625056, 23150612). It has also been reported in the homozygous state in a female patient with HYAL deficiency where this variant was thought to explain the severity of this patient's ocular phenotype. However, this patient underwent exome sequencing at the laboratory who submitted the ClinVar entry; therefore it is unclear if this is an additional patient (PMID: 34906488). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function where this variant was shown to result in protein mislocalization (PMIDs: 10942419, 12037013, 22072390, 28209709, 20729296, 20106869). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
M
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Loss of catalytic residue at M1 (P = 0.0016);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at